We introduce DeepNovoV2, the state-of-the-art neural networks based model for de novo peptide sequencing. Contrary to existing models like DeepNovo or DeepMatch which represents each spectrum as a long sparse vector, in DeepNovoV2, we propose to directly represent a spectrum as a set of (m/z, intensity) pairs . Then we use an order invariant network structure (T-Net) to extract features from the spectrum. By representing spectrums as sets of peaks, we argue that our method is more straightforward and do not have the accuracy-speed/memory trade-off problem . Our experiments show that comparing to the original DeepNovo model, DeepNovoV2 has at least 15\% relative improvement on peptide accuracy.\\%DIF > higher accuracy at the peptide level.
Personalized cancer vaccines are envisioned as the next generation rational cancer immunotherapy. The key step in developing personalized therapeutic cancer vaccines is to identify tumor-specific neoantigens that are on the surface of tumor cells. A promising method for this is through de novo peptide sequencing from mass spectrometry data. In this paper we introduce DeepNovoV2, the state-of-the-art model for peptide sequencing. In DeepNovoV2, a spectrum is directly represented as a set of (m/z, intensity) pairs , therefore it does not suffer from the accuracy-speed/memory trade-off problem. The model combines an order invariant network structure (T-Net) and recurrent neural networks and provides a complete end-to-end training and prediction framework to sequence patterns of peptides . Our experiments on a wide variety of data from different species show that DeepNovoV2 outperforms previous state-of-the-art methods, achieving 13.01-23.95\\%DIF > higher accuracy at the peptide level.
R
We
Personalized cancer vaccines are envisioned as the next generation rational cancer immunotherapy. The key step in developing personalized therapeutic cancer vaccines is to identify tumor-specific neoantigens that are on the surface of tumor cells. A promising method for this is through de novo peptide sequencing from mass spectrometry data. In this paper we
R
neural networks based model for de novo
model for
R
Contrary to existing models like DeepNovo or DeepMatch which represents each spectrum as a long sparse vector, in
In
R
we propose to directly represent a spectrum
a spectrum is directly represented
R
. Then we use
, therefore it does not suffer from the accuracy-speed/memory trade-off problem. The model combines
R
to extract features from the spectrum. By representing spectrums as sets of peaks, we argue that our method is more straightforward and do not have the accuracy-speed/memory trade-off problem
and recurrent neural networks and provides a complete end-to-end training and prediction framework to sequence patterns of peptides
R
show that comparing to the original DeepNovo model,
on a wide variety of data from different species show that
R
has at least 15\% relative improvement on peptide accuracy.
outperforms previous state-of-the-art methods, achieving 13.01-23.95